Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: An in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS)
Files
Publication date
2015-09-28
Authors
Trieste, L.
Della Casa Alberighi, O.
Turchetti, G.
Pierotti, F.
Accame, L.
Lorenzoni, V.
Frenkel, Joost
Gattorno, M.
Quartier, P.
Martini, A.
Editors
Advisors
Supervisors
Document Type
Abstract
Metadata
Show full item recordCollections
License
Abstract
Keywords
Rheumatology, Immunology and Allergy, Pediatrics, Perinatology, and Child Health
Citation
Trieste, L, Della Casa Alberighi, O, Turchetti, G, Pierotti, F, Accame, L, Lorenzoni, V, Frenkel, J, Gattorno, M, Quartier, P & Martini, A 2015, 'Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases : An in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS)', Pediatric Rheumatology, vol. 13, no. Suppl. 1, P185. https://doi.org/10.1186/1546-0096-13-S1-P185